These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 20335052

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low levels of extraneous agents in vaccine starting materials.
    Rouby JC.
    Biologicals; 2010 May; 38(3):354-7. PubMed ID: 20347331
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Considerations for setting the specifications of vaccines.
    Minor P.
    Expert Rev Vaccines; 2012 May; 11(5):579-85. PubMed ID: 22827243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adventitious agents from animal-derived raw materials--a method of risk assessment.
    Foster LG.
    Dev Biol Stand; 1996 May; 88():283-90. PubMed ID: 9119152
    [Abstract] [Full Text] [Related]

  • 8. Risk reduction in biotherapeutic products.
    Ill CR, Dehghani H.
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
    [Abstract] [Full Text] [Related]

  • 9. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M.
    ALTEX; 2001 Mar; 18 Suppl 1():13-47. PubMed ID: 11854853
    [Abstract] [Full Text] [Related]

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization.
    World Health Organ Tech Rep Ser; 2011 Mar; (961):1-428, back cover. PubMed ID: 21699061
    [Abstract] [Full Text] [Related]

  • 11. [Certification of suitability of monographs of the European pharmacopoeia].
    Artiges A.
    Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143
    [Abstract] [Full Text] [Related]

  • 12. Who Expert Committee on Biological Standardization.
    World Health Organization.
    World Health Organ Tech Rep Ser; 2004 Sep; 926():1-109. PubMed ID: 15918537
    [Abstract] [Full Text] [Related]

  • 13. Control of product batches (before and after registration). The French approach.
    Vannier P.
    Dev Biol Stand; 1992 Sep; 79():179-82. PubMed ID: 1286755
    [Abstract] [Full Text] [Related]

  • 14. [Pharmaceutical product quality control and good manufacturing practices].
    Hiyama Y.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010 Sep; (128):1-16. PubMed ID: 21381389
    [Abstract] [Full Text] [Related]

  • 15. New challenges in assuring vaccine quality.
    Dellepiane N, Griffiths E, Milstien JB.
    Bull World Health Organ; 2000 Sep; 78(2):155-62. PubMed ID: 10743279
    [Abstract] [Full Text] [Related]

  • 16. Raw material considerations.
    Lubiniecki AS, Shadle PJ.
    Dev Biol Stand; 1997 Sep; 91():65-72. PubMed ID: 9413684
    [Abstract] [Full Text] [Related]

  • 17. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003 Sep; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [Abstract] [Full Text] [Related]

  • 18. Organic solvents in the pharmaceutical industry.
    Grodowska K, Parczewski A.
    Acta Pol Pharm; 2010 Sep; 67(1):3-12. PubMed ID: 20210074
    [Abstract] [Full Text] [Related]

  • 19. Statistical bases for defining level of assurance.
    Schofield T.
    Dev Biol (Basel); 2006 Sep; 123():209-16; discussion 217-22. PubMed ID: 16566447
    [Abstract] [Full Text] [Related]

  • 20. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2006 Sep; 937():1-461, back cover. PubMed ID: 16836287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.